-
Mashup Score: 1Some vaccinated dialysis patients with no prior COVID-19 infection show low antibody index - 2 year(s) ago
In a letter to the editor of Kidney Medicine Journal, researchers wrote that patients on dialysis without prior COVID-19 infection showed a low antibody response after the COVID-19 vaccine from Johnson & Johnson. “This finding differs from other reports of mRNA vaccines showing high response among dialysis patients,” the researchers wrote.
Source: www.healio.comCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 0Stephen Parodi, MD, discusses U.S. resumption of Johnson & Johnson COVID-19 vaccine - Permanente Medicine - 3 year(s) ago
Kaiser Permanente infectious disease leader says physicians now have a huge task to restore confidence in vaccines.
Source: Permanente MedicineCategories: General Medicine News, Latest HeadlinesTweet-
Permanente physician leader @StephenParodiMD discusses U.S. decision to resume use of #COVID19 #JohnsonAndJohnsonVaccine with @kimbrunhuber of @cnni. https://t.co/zB5bIGM8eX #PermMedLeads
-
-
Mashup Score: 0FDA & CDC Pause J&J Vax - What This Means for Rheum Pts - 3 year(s) ago
Following the FDA and CDC’s news about the J&J vax, two rheumatologists weigh in on what this may mean for their patients.
Source: Docwire NewsCategories: General Medicine News, Latest HeadlinesTweet-
Rheum Roundup: How the #JohnsonandJohnsonVaccine News Affects Immunocompromised Patients, Two Rheumatologists Weigh In, and Much More: https://t.co/NijuAC6lpJ
-
-
Mashup Score: 1Here’s What Rheumatologists Have to Say About J&J Vaccine - 3 year(s) ago
The Johnson & Johnson vaccine news is of significance for immunocompromised patients, who are at a greater risk of COVID-19.
Source: Docwire NewsCategories: General Medicine News, Latest HeadlinesTweet-
Here’s What Rheumatologists Have to Say About the #JohnsonAndJohnsonVaccine https://t.co/4w4UfAk9js
-
-
Mashup Score: 1
Administration of the Johnson & Johnson COVID-19 vaccine has been paused following a few instances of blood clots within weeks of vaccination.
Source: Docwire NewsCategories: General Medicine News, Latest HeadlinesTweet-
What the J and J vaccine news means for immunocompromised patients #COVID19 #Johnson #JohnsonandJohnson #JohnsonAndJohnsonVaccine https://t.co/tmAwUfShFO
-
-
Mashup Score: 0
In a press conference this morning, leadership of the FDA and CDC discussed why they made the decision on this vaccine and announced an ACIP meeting will be held tomorrow to review the data from the adverse events.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#Breaking “While we review the available data, out of an abundance of caution, the #FDA and #CDC are recommending a pause in the use of this #vaccine in the #UnitedStates .” #JohnsonAndJohnsonVaccine https://t.co/omVUH6hksR
-
-
Mashup Score: 0
The Food and Drug Administration and the Centers for Disease Control will stop using the vaccine at federal sites and urge states to do so as well while they examine the safety issues.
Source: www.nytimes.comCategories: Hem/Oncs, Latest HeadlinesTweet-
U.S. Calls for Pause on Johnson & Johnson Vaccine After Clotting Cases #JohnsonAndJohnsonVaccine #CovidVaccine #bloodclot https://t.co/gLSLZtfFjX
-
-
Mashup Score: 0
The NPF recognizes the Ad26.COV2.S vaccine as a major advance in protecting individuals from COVID-19 and recommends individuals receive the first available vaccine.
Source: www.psoriasis.orgCategories: Dermatology, Latest HeadlinesTweet-
With the recent emergency use authorization (EUA) of the #JohnsonAndJohnsonVaccine, the National Psoriasis Foundation (@NPF) #COVID19 Task Force has updated the guidance statements to inform patients and health care providers. https://t.co/Vt3GxgaEvS
-
"Most dialysis patients vaccinated with the #JohnsonandJohnsonvaccine without a previous history of #COVID19 had an undetectable (52%) or inadequate (33%) antibody index." https://t.co/R3ai4OZDlS"